A new study by Grand View Research forecasts a sharp rise in life-sciences M&A across the Middle East as Gulf governments intensify efforts to build a globally competitive biotech and health-technology manufacturing base. With the UAE’s Life Sciences Strategy and Saudi Vision 2030
